LABORATORY ANALYSIS PROCEDURES Clause Samples

The LABORATORY ANALYSIS PROCEDURES clause defines the standards and methods to be followed when conducting laboratory tests or analyses related to the agreement. It typically specifies which protocols, equipment, or accredited laboratories must be used, and may outline requirements for sample collection, handling, and reporting of results. By establishing clear procedures, this clause ensures consistency, reliability, and accuracy in laboratory testing, thereby reducing disputes over test results and maintaining quality control.
LABORATORY ANALYSIS PROCEDURES. A. The testing or processing phase shall consist of a two-step procedure. A specimen initially testing positive will undergo an additional confirmatory test. An initial positive report will not be considered positive, rather it will be classified as confirmation pending or presumptive positive. B. The initial test will be performed by an immunoassay test. The cutoff levels (positive detection) for screening tests are expressed in nanograms per milliliter (ng/ml), or billionths of a gram per thousandths of a liter and will be according to current DOT standards at the time of testing. C. A confirmation test will be performed on all initial positive tests. The cutoff levels for confirmation tests are according to current DOT standards at the time of testing. D. All test results are to be reviewed by a Certifying Scientist. Test results must be completed as soon as possible. E. Tests which are below the levels set forth above shall be determined as negative. If test results are negative, all Human Resources documentation regarding supervisory observations and testing will be destroyed and the Union will be notified. F. A MRO shall examine all positive confirmed test results to determine if there is an alternative medical explanation for the positive test result. Before making a final decision as to whether a positive test is valid, the MRO must provide the employee with an opportunity to discuss the test result. If the MRO determines there is a legitimate medical explanation for the positive test result, the MRO shall report to the Employer that the test is negative.
View SourceView Similar (8)
LABORATORY ANALYSIS PROCEDURES. All laboratory security, chain of custody, transporting and receiving of specimens, specimen processing, retesting, storage of specimens, instrument calibration and reporting of results shall
View SourceView Similar (2)
LABORATORY ANALYSIS PROCEDURES. The City of Edwardsville will use Department of Health and Human Services (“DHHS”) and NIDA certified drug testing laboratories. Basic laboratory analysis procedures require: 1. Use of chain of custody document to track specimens throughout lab processes. 2. Accession area of lab for storage of specimens. Small portions (aliquots) are used for the analysis. 3. Screening of specimens using immunoassay. Cut-off levels are established to determine if a specimen contains drug metabolites. If the amount of metabolite is below the cutoff, the specimen is reported as negative. 4. Specimens that are positive in the initial screening to be tested on gas chromatography/mass spectrometry (GC/MS). If the amount of metabolite is above the cutoff level, the specimen is confirmed positive; if it is below the cutoff level, it is reported as a negative result. All results are reported (in writing or by electronic means, not by telephone) to the medical review officer. Quantitative levels (the specific amount of metabolite found) are reported only to the MRO when requested. The MRO receives the certified copy of the lab results. The laboratory will send a quarterly report of all testing conducted for the City of Edwardsville. This report contains statistical data, not individual specimen results. The laboratory will retain all records related to the specimens for a minimum of two (2) years. The laboratory will provide secure storage of all positive specimens for at least one (1) year. The City of Edwardsville, the DOT agency, or DHHS may inspect the laboratory at any time.
View Source
LABORATORY ANALYSIS PROCEDURES. The initial test is performed by an immunoassay test. The cutoff levels for screening tests are listed below and are expressed in nanograms per milliliter (ng/ml), or billionths of a gram per thousandths of a liter: Marijuana metabolites Cocaine metabolites Opiate metabolites Phencyclidine Amphetamines 100 ng/ml 300 ng/ml 300 ng/ml 25 ng/ml 1,000 ng/ml A confirmation test is performed on all initial positive tests. The cutoff levels for confirmation tests are: Marijuana metabolites 15 ng/ml Cocaine metabolites 150 ng/ml Opiates Morphine 300 ng/ml Codeine 300 ng/ml Phencyclidine 25 ng/ml Amphetamines Amphetamine 500 ng/ml Methamphetamine 500 ng/ml A test will only be deemed positive if it exceeds the cutoff levels for the confirmation test and only after a qualified Medical Review Officer (MRO) has met and discussed the results with the employee to determine if there is a legitimate medical explanation for the positive test result. If there is a legitimate explanation, the MRO shall report to the employer that the test is negative. A confirmation test will only be given when the initial test cutoff levels are exceeded. The Employer may use the positive test as evidence of impairment. Such evidence shall not be deemed to be conclusive, nor shall it preclude the introduction of other evidence on the issue of impairment. The employee shall be compensated for all time lost from work as a result of the order to take the test; in addition, the employee shall be compensated at the rate of double time the employee's straight time hourly rate for all hours in excess of their scheduled work day that the employee is involved in activities as a result of the order to take the test.
View Source
LABORATORY ANALYSIS PROCEDURES. All laboratory security, chain of custody, transporting and receiving of specimens, specimen processing, retesting, storage of specimens, instrument calibration and reporting of results shall be in accordance with Section 112.0455, Florida Statues, and its attendant rules in Rule 59A-24.006, Florida Administrative Code.
View Source
LABORATORY ANALYSIS PROCEDURES. The initial test will be enzyme immunoassay. Each specimen identified as positive on the initial test shall be confirmed using gas chromatography/mass spectrometry techniques.
View Source

Related to LABORATORY ANALYSIS PROCEDURES

  • Protocols Each party hereby agrees that the inclusion of additional protocols may be required to make this Agreement specific. All such protocols shall be negotiated, determined and agreed upon by both parties hereto.

  • Research Use Reporting To assure adherence to NIH GDS Policy, the PI agrees to provide annual Progress Updates as part of the annual Project Renewal or Project Close-out processes, prior to the expiration of the one (1) year data access period. The PI who is seeking Renewal or Close-out of a project agree to complete the appropriate online forms and provide specific information such as how the data have been used, including publications or presentations that resulted from the use of the requested dataset(s), a summary of any plans for future research use (if the PI is seeking renewal), any violations of the terms of access described within this Agreement and the implemented remediation, and information on any downstream intellectual property generated from the data. The PI also may include general comments regarding suggestions for improving the data access process in general. Information provided in the progress updates helps NIH evaluate program activities and may be considered by the NIH GDS governance committees as part of NIH’s effort to provide ongoing stewardship of data sharing activities subject to the NIH GDS Policy.

  • Procurement Procedures 11.1 The Recipient must secure the best value for money and shall act in a fair, open and non-discriminatory manner in all purchases of goods and services.